Nimustine
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| N'-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-(2-chloroethyl)-N-nitrosourea | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | IV |
| Identifiers | |
| CAS number | 42471-28-3  |
| ATC code | L01AD06 |
| PubChem | CID 39214 |
| UNII | 0S726V972K |
| KEGG | D08276 |
| Chemical data | |
| Formula | C9H13ClN6O2 |
| Mol. mass | 272.69 g/mol |
|
|
 (what is this?) (verify) |
|
Nimustine (INN) is a nitrosourea alkylating agent.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
